Brian O Mahony/X
Apr 26, 2026, 06:28
Brian Mahony: Real-World Positioning of Rebalancing Agents
Brian Mahony,CEO of Irish Haemophilia Society, former President of WFH and EHC,shared a post on X:
“Mahlangu on re-balancing agents WFH Congress 2026.
Bypassing agents increase thrombosis risk.
Avoid stacking therapies and apply strict protocol driven care.
Some of the thrombosis cases seen were where protocol not observed 1/2.”
See more in the gallery.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials